Workflow
FREEWON(688678)
icon
Search documents
5.26犀牛财经晚报:信用债ETF开展质押式回购即将实施 美团一季度收入865.5亿元
Xi Niu Cai Jing· 2025-05-26 10:23
Group 1 - Credit bond ETFs will soon implement a general pledge-style repurchase business, with multiple public fund institutions' credit bond ETFs meeting the criteria to be included in the repurchase pledge library [1] - The average dividend yield of over 70% of A-share listed banks exceeds 4%, with some banks surpassing 8%, making bank stocks more attractive compared to traditional savings [1] - The banking sector has seen a year-to-date increase of 7.66%, driven by a high dividend strategy, while regional banks have shown stronger performance [1] Group 2 - AI demand is expected to stimulate significant growth in enterprise SSDs, with prices of NAND Flash likely to rise by 10% in Q3 2025 due to tight supply [2] - A new 3D printing device developed by a research team at the University of Washington allows for more precise modeling of human tissues [2] - The popularity of traditional cultural experiences during the Dragon Boat Festival has surged by 105% compared to last year, with significant increases in family travel and car rentals [2] Group 3 - Meituan reported a revenue of 86.55 billion yuan for Q1 2025, marking an 18.1% year-on-year increase, with a profit of 10 billion yuan, up 87.3% [3] - The merger between Zhongke Shuguang and Haiguang Information aims to enhance competitiveness in the high-end chip market, responding to industry trends and national strategic needs [4] - Shanghai Suhe Bay Group is offering a 51% stake in its real estate development company for a minimum price of 850 million yuan [5] Group 4 - Lide Health Technology completed nearly 100 million yuan in angel financing to accelerate technology development and market expansion [6] - Three squirrels have submitted their H-share issuance application to the Hong Kong Stock Exchange, pending approval from relevant regulatory bodies [6] - Country Garden's liquidation hearing has been postponed to August 11, as the company seeks more time for its overseas debt restructuring involving 14.074 billion USD [7] Group 5 - Pingzhi Information signed a framework agreement worth approximately 246 million yuan with China Telecom for AI computing power services [11] - Hemai Co. signed a 1 billion yuan cooperation agreement for household photovoltaic systems, which is expected to positively impact its future performance [12] - The Shanghai Composite Index experienced a slight decline of 0.05%, with nuclear power stocks showing significant gains [13]
福立旺(688678) - 关于实施2024年年度权益分派调整“福立转债”转股价格的公告
2025-05-26 09:31
| 证券代码:688678 | 证券简称:福立旺 | 公告编号:2025-043 | | --- | --- | --- | | 转债代码:118043 | 转债简称:福立转债 | | 根据中国证券监督管理委员会关于可转换公司债券发行的有关规定《福立旺 精密机电(中国)股份有限公司向不特定对象发行可转换公司债券募集说明书》(以 下简称"募集说明书")的相关条款,"福立转债"在本次发行后,若公司发生派 送股票股利、转增股本、增发新股(不包括因本次发行的可转换公司债券转股而 增加的股本)、配股以及派发现金股利等情况,公司将按上述条件出现的先后顺序, 依次对转股价格进行调整。 调整前转股价格:15.00 元/股 调整后转股价格:14.90 元/股 转股价格调整实施日期:2025 年 6 月 3 日 福立旺精密机电(中国)股份有限公司(以下简称"公司")2024 年年度利润 分配方案为:以实施权益分派股权登记日登记的总股本为基数,向全体股东每 10 股派发现金红利 1.00 元(含税),不转增,不送红股。上述权益分派方案已经 2025 年 5 月 15 日召开的公司 2024 年年度股东大会审议通过,具体内容详见公司 ...
福立旺(688678) - 股东询价转让定价情况提示性公告
2025-05-26 09:30
根据 2025 年 5 月 26 日询价申购情况,初步确定的本次询价转让价格为 17.66 元/股。 一、本次询价转让初步定价 | 证券代码:688678 | 证券简称:福立旺 | 公告编号:2025-044 | | --- | --- | --- | | 转债代码:118043 | 转债简称:福立转债 | | 福立旺精密机电(中国)股份有限公司 股东询价转让定价情况提示性公告 WINWIN OVERSEAS GROUP LIMITED(以下简称"出让方")保证向福 立旺精密机电(中国)股份有限公司(以下简称"福立旺"、"公司")提供的 信息内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其真实性、准确 性和完整性依法承担法律责任。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要内容提示: 二、风险提示 (一)本次询价转让受让方及受让股数仅为初步结果,尚存在拟转让股份被 司法冻结、扣划等风险。询价转让的最终结果以中国证券登记结算有限责任公司 上海分公司最终办理结果为准。 1 (二)本次询价转让不涉及公司控制权变更,不会影响公司治理结构和持续 经营。 特此公告。 2 (一)经向机构 ...
福立旺(688678) - 2024年年度权益分派实施公告
2025-05-26 09:30
| 证券代码:688678 | 证券简称:福立旺 | 公告编号:2025-042 | | --- | --- | --- | | 转债代码:118043 | 转债简称:福立转债 | | 福立旺精密机电(中国)股份有限公司2024年年度 权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: | 股权登记日 | 除权(息)日 | 现金红利发放日 | | --- | --- | --- | | 2025/5/30 | 2025/6/3 | 2025/6/3 | 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经公司2025年 5月 15 日的2024年年度股东大会审议通过。 二、 分配方案 1. 发放年度:2024年年度 2. 分派对象: 截至股权登记日下午上海证券交易所收市后,在中国证券登记结算有限责任 公司上海分公司(以下简称"中国结算上海分公司")登记在册的本公司全体股东。 3. 分配方案: 本次利润分配以方案实施前的公司总股本259,268,836股为基数,每股派发现 金红利0.10元( ...
福立旺:询价转让价格为17.66元/股
news flash· 2025-05-26 09:02
福立旺(688678.SH)公告称,根据询价申购情况,初步确定的本次询价转让价格为17.66元/股,参与报价 的机构投资者家数为11家,合计有效认购股份数量为16,160,000股,对应的有效认购倍数为1.25倍。初 步确定受让方为9家机构投资者,拟受让股份总数为12,970,000股。此次询价转让不涉及公司控制权变 更,不会影响公司治理结构和持续经营。 ...
福立旺控股股东拟询价转让 2020年上市两募资共14.8亿
Zhong Guo Jing Ji Wang· 2025-05-26 08:35
Core Viewpoint - Fuliwang (688678.SH) plans to transfer 12,970,000 shares, representing 5.00% of its total share capital, to WINWIN OVERSEAS GROUP LIMITED for financial support to the company [1][2]. Group 1: Share Transfer Details - The transfer is initiated by WINWIN, which holds 45.02% of Fuliwang's shares, and the transfer is not conducted through secondary market trading [2][3]. - WINWIN will provide all proceeds from the share transfer, after tax deductions, as financial support to Fuliwang for a minimum of one year [1][2]. - The transfer price will be determined based on the average trading price of the stock over the 20 trading days prior to the invitation date, with a minimum price set at 70% of that average [3]. Group 2: Financial Background - Fuliwang was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 23, 2020, raising a total of 783.47 million yuan (approximately 78.25 million) [3][4]. - The company has raised a total of 1.482 billion yuan (approximately 148.2 million) since its listing [5]. - The proceeds from the initial public offering were intended for projects including a precision metal component manufacturing center and a research and development center [3].
福立旺(688678) - 中信证券股份有限公司关于福立旺精密机电(中国)股份有限公司股东向特定机构投资者询价转让股份相关资格的核查意见
2025-05-23 14:18
中信证券股份有限公司 关于福立旺精密机电(中国)股份有限公司股东 向特定机构投资者询价转让股份 相关资格的核查意见 广东省深圳市福田区中心三路 8 号卓越时代广场(二期)北座 1 中信证券股份有限公司(以下简称"中信证券")受福立旺精密机电(中国) 股份有限公司(以下简称"福立旺")股东 WINWIN OVERSEAS GROUP LIMITED (以下简称"出让方")委托,组织实施本次福立旺首发前股东向特定机构投资 者询价转让(以下简称"本次询价转让")。 根据《关于在上海证券交易所设立科创板并试点注册制的实施意见》《科创 板上市公司持续监管办法(试行)》《上海证券交易所科创板股票上市规则(2025 年 4 月修订)》《上海证券交易所科创板上市公司自律监管指引第 4 号——询价 转让和配售(2025 年 3 月修订)》(以下简称"《询价转让和配售指引》")等 相关规定,中信证券对参与本次询价转让股东的相关资格进行核查,并出具本核 查意见。 一、本次询价转让的委托 (1)基本情况 中信证券核查了 WINWIN OVERSEAS GROUP LIMITED 提供的工商登记文 2 件并对企业人员访谈,WINWIN ...
福立旺(688678) - 股东询价转让计划书
2025-05-23 14:16
| 证券代码:688678 | 证券简称:福立旺 | 公告编号:2025-041 | | --- | --- | --- | | 转债代码:118043 | 转债简称:福立转债 | | 福立旺精密机电(中国)股份有限公司 股东询价转让计划书 WINWIN OVERSEAS GROUP LIMITED(以下简称"出让方")保证向福 立旺精密机电(中国)股份有限公司(以下简称"福立旺"或"公司")提供的 信息内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其真实性、准确 性和完整性依法承担法律责任。 | 序号 | 股东名称 | 持股数量(股) | 持股占总股本比例 | | --- | --- | --- | --- | | 1 | WINWIN | 116,730,407 | 45.02% | 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要内容提示: 拟参与福立旺首发前股东询价转让(以下简称"本次询价转让")的股东 为 WINWIN OVERSEAS GROUP LIMITED(以下简称"WINWIN"); 出让方拟转让股份的总数为 12,970,000 股,占公司总股本的比例为 5 ...
太平洋医药日报:IONIS反义寡核苷酸疗法OLEZARSEN三期临床成功
Xin Lang Cai Jing· 2025-05-23 02:27
Industry News - Ionis announced positive topline results for its antisense oligonucleotide therapy Tryngolza (Olezarsen) in the Phase 3 Essence clinical trial, significantly reducing triglyceride levels in patients after 6 months and achieving all key secondary endpoints with statistical significance [2] Company News - Health元 announced that its subsidiary LIAN SGP plans to acquire 64.81% of Vietnamese listed company Imexpharm for approximately 15.87 million RMB, which is a leading pharmaceutical company in Vietnam with products that include antibiotics and cardiovascular drugs, showing high synergy with Health元's existing products [3] - 众生药业 reported that its subsidiary 众生睿创's innovative drug Angladiwe tablets received approval from the National Medical Products Administration, being the first global RNA polymerase PB2 protein inhibitor for treating adult patients with uncomplicated influenza A [3] - 科伦药业 announced that its subsidiary 科伦博泰's new indication application for the ADC drug sac-TMT has been accepted by CDE, aimed at treating adults with HR+ and HER2- breast cancer who have previously received endocrine therapy and other systemic treatments [3] - 艾力斯 announced that its KRASG12C inhibitor, citric acid gorasetinib tablets, has received approval from the National Medical Products Administration for treating adult patients with advanced non-small cell lung cancer with KRASG12C mutations who have received at least one systemic treatment [4]
福立旺(688678) - 关于实施2024年年度权益分派时可转债转股价格调整暨转股连续停牌的提示性公告
2025-05-20 09:16
证券停复牌情况:适用 | 证券代码:688678 | 证券简称:福立旺 | 公告编号:2025-040 | | --- | --- | --- | | 转债代码:118043 | 转债简称:福立转债 | | 福立旺精密机电(中国)股份有限公司 关于实施 2024 年年度权益分派时可转债 转股价格调整暨转股连续停牌的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 因实施权益分派,本公司的相关证券停复牌情况如下:权益分派公告前一交易 日(2025 年 5 月 26 日)至权益分派股权登记日期间,本公司可转债将停止转股。 | 证券代码 | 证券简称 | 停复牌类型 | 停牌起始日 | 停牌期 | 停牌终 | 复牌日 | | --- | --- | --- | --- | --- | --- | --- | | | | | | 间 | 止日 | | | 118043 | 福立转债 | 可转债转股停牌 | 2025/5/26 | | | | 因实施权益分派,"福立转债"将相应调整转股价格,从 15.00 元/ ...